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family members expressed almost exclusively in the placenta and no equivalent for 70 placental growth hormone gene [14] . However, only a small subset of these hormones 71 possess the capacity to activate the prolactin receptor [15] . In humans there are two 72 functional prolactin family members expressed in the placenta (chorionic 73 somatomammotropin hormone 1 and 2) encoding placental lactogen, and one placental 74 growth hormone gene [16] . One of the key changes in pregnancy thought to be induced by 75 a growth hormone-like activity is the increase maternal insulin resistance required to 76 channel maternal glucose to the fetus [17] . Glucose is transported via a passive process 77 that requires a higher concentration in the maternal circulation than in the fetus. Insulin 78 resistance contributes to this gradient but must be balanced by the ability to respond 79 rapidly to meals in order to avoid dangerously high levels of blood glucose. This balance is 80 achieved, in part, through the prolactin-like function of this gene family up-regulating 81 maternal islet function and accommodating the increased demand for insulin during 82 pregnancy [18, 19] . Placental lactogens also play an important role in preparing the new 83 mother to provide nutrients after birth by priming the mammary gland for lactation [20] . 84
Placental lactogens may additionally be involved in the induction of maternal care. Both 85 pituitary prolactin and placental lactogen have been shown to stimulate maternal care in 86 non-pregnant rodents likely influencing maternal care through their interaction with the 87 maternal prolactin receptor, most clearly demonstrated in rodents [21] . 88
89
In mice and humans, placental lactogens are expressed by derivatives of the trophoblast 90 lineage, a specialised cell type that emerges from the first differentiation event in 91 development [22] . Early in pregnancy, trophoblast cells contribute to the choriovitelline 92 (yolk sac) placenta, a structure that is replaced as gestation proceeds by the 93 chorioallantoic (mature) placenta. In mice, there are four main region of the chorioallantoic 94 placenta: the maternally-derived decidua, a single layer of cells with giant nuclei called the 95 secondary parietal trophoblast giant cells (TGCs), the junctional zone and the labyrinth 96 been reported in a number of studies on human fetal growth restriction, fetal death and low 157 birth weight [44] . In our recent study on women with a perception of reduced fetal 158 movements (RFM), we found placental PHLDA2 expression was 2.3 fold higher in RFM 159 pregnancies resulting in delivery of a growth restricted infant compared with a normal birth 160 weight infant [45] . Importantly, we found a significant inverse association between 161 placental PHLDA2 levels and maternal serum placental lactogen (hPL) levels suggesting 162 that PHLDA2 may regulate the production of placental hormones in human pregnancies. 163
In another study focusing on prenatal depression, we examined placental expression 164 levels of four genes, PHLDA2, CDKN1C, PEG3 and PEG10, based on the conserved 165 imprinting status between mouse and human and their predicted role in regulating 166 production of placental hormones [32] . In women with clinically diagnosed depression 167 during pregnancy, we observed significantly lower expression of placental PEG3. We also 168 found low placental PEG3 in pregnancies where women reported a depressed mood 169 assessed using two self-rating psychometric questionnaires: Edinburgh Postnatal 170 Depression Scale (EPDS), used as a measure of maternal prenatal depressive symptoms 171 
